ABSTRACT
The purpose of this study was to examine the effect of specific endurance (Yo-Yo Intermittent recovery test level 1, Yo-Yo IR1) on match performance in male youth soccer. Twenty-one young, male soccer players (age 14.1 +/- 0.2 years) were involved in the study. Players were observed during international championship games of corresponding age categories and completed the Yo-Yo IR1 on a separate occasion. Physical (distance coverage) and physiological match demands were assessed using Global Positioning System technology and heart rate (HR) short-range telemetry, respectively. During the match (two 30-minutes halves), players covered 6,204 +/- 731 m, of which 985 +/- 362 m (16%) were performed at high intensities (speed >13 kmxh, HIA). A significant decrement (3.8%, p = 0.003) in match coverage was evident during the second half. No significant (p = 0.07) difference between halves was observed for HIA (p = 0.56) and sprint (speed >18 kmxh, SPR) distances. During the first and second halves, players attained the 86 +/- 5.5 and 85 +/- 6.0% of HRmax (p = 0.17), respectively. Peak HR during the first and second halves were 100 +/- 4 and 99.4 +/- 4.7% of HRmax, respectively. Yo-Yo IR1 performance (842 +/- 352 m) was significantly related to match HIA (r = 0.77, p < 0.001) and total distance (r = 0.65, p = 0.002). This study's results showed that specific endurance, as determined by Yo-Yo IR1 performance, positively affects physical match performance in male young soccer players. Consequently, the Yo-Yo IR1 test may be regarded as a valid test to assess game readiness and guide training prescription in male youth soccer players.
Subject(s)
Athletic Performance , Physical Endurance/physiology , Physical Fitness , Soccer/physiology , Adolescent , Heart Rate , Humans , MaleABSTRACT
The mother-to-child transmission in Toxoplasma gondii infection occurs only when the infection is acquired for the first time during pregnancy. The prenatal and early postnatal diagnosis can only be achieved by serological testing. Serologic tests have different sensitivities, specificities and complexities, so that different tests in more than one blood sample are necessary for the diagnosis. Serological follow-up of the infants should be conducted during the first year of life or until the diagnosis of congenital toxoplasmosis can be ruled out. Treatment recommendations try to reduce the transmission rate and the risk of congenital damage. Congenital toxoplasmosis incidence rate is approximately 5 per 1000 births, but can be reduced to 0.5 per 1000 with an active screening program. The aim of this consensus group was to review the scientific literature on congenital toxoplasmosis and prepare a statement on prevention, diagnosis and treatment that should be implemented in our country.
Subject(s)
Infectious Disease Transmission, Vertical/prevention & control , Mass Screening , Pregnancy Complications, Parasitic , Toxoplasmosis, Congenital , Antibodies, Protozoan/blood , Argentina , Female , Humans , Infant, Newborn , Neonatal Screening , Pregnancy , Pregnancy Complications, Parasitic/diagnosis , Pregnancy Complications, Parasitic/prevention & control , Pregnancy Complications, Parasitic/therapy , Prenatal Diagnosis , Risk Factors , Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis, Congenital/therapy , Toxoplasmosis, Congenital/transmissionABSTRACT
La transmisión de la infección por Toxoplasma gondii de la madre al hijo ocurre cuando la madre se infecta por primera vez en el transcurso del embarazo. Tanto el diagnóstico prenatal, como el del primer año de vida se basa en pruebas serológicas; y la mayoría de las veces es necesario realizar más de una de estas pruebas ya que tienen distintos porcentajes de sensibilidad y/o especificidad así como distintos niveles de complejidad. El recién nacido requiere seguimiento serológico en el primer año de vida o hasta que se descarte el diagnóstico de toxoplasmosis congénita. El diagnóstico temprano de la infección, en la mujer embarazada, permite un tratamiento oportuno y se indica con el propósito de reducir la tasa de transmisión y el daño congénito. Es posible que con un programa activo, de prevención y tratamiento temprano, se pueda reducir la tasa de incidencia de la toxoplasmosis congénita de alrededor del 5 por mil nacimientos a 0.5 por mil. El objetivo de este consenso fue revisar la literatura científica para la prevención, el diagnóstico y el tratamiento de la toxoplasmosis congénita, para que se pueda implementar en nuestro país.
The mother-to-child transmission in Toxoplasma gondii infection occurs only when the infection is acquired for the first time during pregnancy. The prenatal and early postnatal diagnosis can only be achieved by serological testing. Serologic tests have different sensitivities, specificities and complexities, so that different tests in more than one blood sample are necessary for the diagnosis. Serological follow-up of the infants should be conducted during the first year of life or until the diagnosis of congenital toxoplasmosis can be ruled out. Treatment recommendations try to reduce the transmission rate and the risk of congenital damage. Congenital toxoplasmosis incidence rate is approximately 5 per 1000 births, but can be reduced to 0.5 per 1000 with an active screening program. The aim of this consensus group was to review the scientific literature on congenital toxoplasmosis and prepare a statement on prevention, diagnosis and treatment that should be implemented in our country.
Subject(s)
Female , Humans , Infant, Newborn , Pregnancy , Infectious Disease Transmission, Vertical/prevention & control , Mass Screening , Pregnancy Complications, Parasitic , Toxoplasmosis, Congenital , Argentina , Antibodies, Protozoan/blood , Neonatal Screening , Prenatal Diagnosis , Pregnancy Complications, Parasitic/diagnosis , Pregnancy Complications, Parasitic/prevention & control , Pregnancy Complications, Parasitic/therapy , Risk Factors , Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis, Congenital/therapy , Toxoplasmosis, Congenital/transmissionABSTRACT
La infección hospitalaria es uno de los principales indicadores de calidad en la atención médica; su prevención y control debe ser una de las principales metas de todo el equipo de salud
Subject(s)
Male , Female , Humans , Cross Infection , Infection Control , Hand Disinfection , Hand HygieneSubject(s)
Humans , Male , Adult , Female , Urinary Tract/pathology , Tuberculosis, Urogenital/diagnosis , Tuberculosis, Urogenital/therapy , ArgentinaABSTRACT
La mucormicosis, es una infección oportunista poco frecuente y potencialmente letal, causada por hongos del orden de los Mucorales. El mucor, es un saprófito obicuo de distribución geográfica universal, que se encuentra en el moho de las frutas, pan, desechos orgánicos variados y también en cintas adhesivas no estiriles. Afecta más frecuentemente a pacientes inmunocomprometidos (diabeticos, leucemia, sida etc.)...(AU)
Subject(s)
Humans , Child , Female , Mucormycosis/diagnosis , Opportunistic Infections/epidemiology , Opportunistic Infections/therapy , Mucor/classification , Mucorales/pathogenicity , ArgentinaABSTRACT
La mucormicosis, es una infección oportunista poco frecuente y potencialmente letal, causada por hongos del orden de los Mucorales. El mucor, es un saprófito obicuo de distribución geográfica universal, que se encuentra en el moho de las frutas, pan, desechos orgánicos variados y también en cintas adhesivas no estiriles. Afecta más frecuentemente a pacientes inmunocomprometidos (diabeticos, leucemia, sida etc.)...
Subject(s)
Humans , Child , Female , Mucor , Mucorales , Mucormycosis , Opportunistic Infections , ArgentinaABSTRACT
La historia relatada y los conceptos expresados, son exclusivamente personales. Los dedico con todo cariño al Hospital Sor María Ludovica y a la Universidad Nacional de La Plata, a quienes les debo todo
Subject(s)
History , Infectious Disease Medicine , PediatricsABSTRACT
La historia relatada y los conceptos expresados, son exclusivamente personales. Los dedico con todo cariño al Hospital Sor María Ludovica y a la Universidad Nacional de La Plata, a quienes les debo todo
Subject(s)
History , Infectious Disease Medicine , PediatricsSubject(s)
Humans , Female , Middle Aged , Tuberculosis, Hepatic/diagnosis , Tuberculosis, Hepatic/therapy , Tuberculosis, HepaticABSTRACT
Excelente, conciso y actualizado texto sobre diagnóstico y tratamiento de Enfermedades Infecciosas y temas relacionados (por ej.: infecciones en el paciente con cáncer, fiebre de origen desconocido, uso racional de antibióticos en el hospital, infecciones vinculadas con catéteres vasculares, causas infecciosas de esterilidad, infecciones en pacientes con sistemas de derivación o shunt ventrículo-peritoneal, etc, etc). Infecciones del aparato respiratorio. Del aparato circulatorio. Del sistema nervioso. Del aparato digestivo. Del aparato genitourinario. Oculares. Osteoarticulares. De piel y partes blandas. Infecciones severas y su control. En pacientes inmunocomprometidos. Patología infecciosa prenatal y perinatal. Enfermedades exantematicas. Infecciones ganglionares y glandulares. Toma de muestras para bacteriología. Antibioticoterapia. Inmunoprofilaxis y quimioprofilaxis en condiciones especiales
Subject(s)
Male , Female , Humans , Infant, Newborn , Infant , Child , Adult , Aged , Communicable Diseases/therapy , Cross Infection/prevention & control , Bacterial Infections/diagnosis , Abortion, Septic/diagnosis , Abortion, Septic/drug therapy , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/diagnosis , Arthritis, Infectious/drug therapy , Catheterization, Peripheral/adverse effects , Cellulite/drug therapy , Shock, Septic/therapy , Shock, Septic/drug therapy , Blood Specimen Collection/standards , Pregnancy Complications, Infectious/classification , Pregnancy Complications, Infectious/drug therapy , Croup/therapy , Cerebrospinal Fluid Shunts/adverse effects , Diabetes Mellitus/complications , Pelvic Inflammatory Disease/etiology , Sexually Transmitted Diseases, Bacterial/drug therapy , Sexually Transmitted Diseases, Viral/diagnosis , Endocarditis, Bacterial/drug therapy , Splenectomy/adverse effects , Exanthema/drug therapy , Rheumatic Fever/drug therapy , Fever of Unknown Origin/etiology , Muscle Hypotonia/etiology , Immunocompromised Host/physiology , Puerperal Infection/drug therapy , Bacterial Infections/classification , Bacterial Infections/drug therapy , Respiratory Tract Infections/therapy , Respiratory Tract Infections/drug therapy , Urinary Tract Infections/drug therapy , Renal Insufficiency, Chronic/complications , Meningitis/drug therapy , Myocarditis/therapy , Infectious Mononucleosis/immunology , Bites, Human/drug therapy , Bites and Stings/drug therapy , Neutropenia/complications , Osteomyelitis/drug therapy , Paralysis/etiology , Parotitis/classification , Pericarditis/drug therapy , Pneumonia/classification , Pneumonia/drug therapy , Acquired Immunodeficiency Syndrome/drug therapy , Bacteriological Techniques , Uveitis/etiologyABSTRACT
Excelente, conciso y actualizado texto sobre diagnóstico y tratamiento de Enfermedades Infecciosas y temas relacionados (por ej.: infecciones en el paciente con cáncer, fiebre de origen desconocido, uso racional de antibióticos en el hospital, infecciones vinculadas con catéteres vasculares, causas infecciosas de esterilidad, infecciones en pacientes con sistemas de derivación o shunt ventrículo-peritoneal, etc, etc). Infecciones del aparato respiratorio. Del aparato circulatorio. Del sistema nervioso. Del aparato digestivo. Del aparato genitourinario. Oculares. Osteoarticulares. De piel y partes blandas. Infecciones severas y su control. En pacientes inmunocomprometidos. Patología infecciosa prenatal y perinatal. Enfermedades exantematicas. Infecciones ganglionares y glandulares. Toma de muestras para bacteriología. Antibioticoterapia. Inmunoprofilaxis y quimioprofilaxis en condiciones especiales
